V-Chip plus+in-guide user interface apparatus and method for programmable blocking of television and other viewable programming, such as for parental control of a television receiver
    1.
    发明授权
    V-Chip plus+in-guide user interface apparatus and method for programmable blocking of television and other viewable programming, such as for parental control of a television receiver 失效
    用于可编程屏蔽电视和其他可视化节目的V-Chip plus +导向用户界面装置和方法,例如用于家长对电视接收机的控制

    公开(公告)号:US06701523B1

    公开(公告)日:2004-03-02

    申请号:US09398963

    申请日:1999-09-16

    IPC分类号: H04N716

    摘要: A system for restricting access to television programs comprising an input for accepting cursor movement and selection commands. The system includes a display that depicts a two dimensional matrix composed of rows and columns of tiles, wherein either the rows of tiles or the columns of tiles correspond to overall program ratings and either the rows of tiles or the columns of tiles correspond to specific program content indications and depicts highlighting of individual tiles or groups of tiles based on the cursor movement commands. The system further includes means for blocking or allowing viewing of television programs based on the overall program ratings and specific content ratings of the rows and columns corresponding the highlighted tiles when a selection command is entered into the input.

    摘要翻译: 一种用于限制访问电视节目的系统,包括用于接受光标移动和选择命令的输入。 该系统包括描绘由瓦片的行和列组成的二维矩阵的显示器,其中瓦片的行或瓦片的列对应于总体程序评级,瓦片的行或瓦片的列对应于特定程序 内容指示,并基于光标移动命令描绘各个瓦片或瓦片组的突出显示。 该系统还包括当选择命令输入到输入中时,基于总体节目评级和对应于突出显示的瓦片的行和列的特定内容等级来阻止或允许观看电视节目的装置。

    Polymorphism of the human GluR-5 gene and risk factor for alzheimer disease
    2.
    发明授权
    Polymorphism of the human GluR-5 gene and risk factor for alzheimer disease 失效
    人类GluR-5基因的多态性和阿尔茨海默病的危险因素

    公开(公告)号:US06255054B1

    公开(公告)日:2001-07-03

    申请号:US09392486

    申请日:1999-09-09

    IPC分类号: C12Q168

    CPC分类号: C12Q1/6883 C12Q2600/156

    摘要: The present invention concerns a method and kit for determining if a subject is at increased or decreased risk of developing Alzheimer's disease. The invention further concerns vectors, transformed cells or transgenic mammals which can be used in a method for the screening of compound capable of modulating the expression of the GluR-5 gene or the activity of the GluR-5 receptor. The compounds selected by the method of the invention, as medicament for the treatment or the prevention of Alzheimer's disease, also form part of the present invention.

    摘要翻译: 本发明涉及一种用于确定受试者是否处于增加或减少发展为阿尔茨海默病的风险的方法和试剂盒。 本发明还涉及可用于筛选能够调节GluR-5基因表达的化合物或GluR-5受体活性的化合物的方法中的载体,转化细胞或转基因哺乳动物。 通过本发明方法选择的化合物作为治疗或预防阿尔茨海默氏病的药物也构成本发明的一部分。